Smart diabetes monitoring trial aims to improve insulin management

NCT ID NCT06185296

Recruiting now Disease control Sponsor: Aalborg University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This trial tests whether a smart telemonitoring system can help people with type 2 diabetes who use insulin. Participants will use a continuous glucose monitor, insulin pen, and Fitbit at home. One group will also get decision-support algorithms to guide insulin adjustments. The study will compare blood sugar control among three groups over three months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: intelligent telemonitoring system (continuous glucose monitor, insulin pen, Fitbit, and decision-support algorithms)
What this could lead to: If it works, this could give doctors and patients a smarter way to manage insulin dosing at home, leading to better blood sugar control.
What could go wrong: This is a small, early-stage trial with only 51 participants, so results may not apply to everyone. The technology may be too complex for some users.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES TREATED WITH INSULIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus Insulin Resistance type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 2 DIABETES TREATED WITH INSULIN

Contacts and locations

Locations

Department of Endocrinology
RECRUITING

Aalborg, North Jutland, 9000, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.